Senior Accountant

Locus Biosciences is seeking a highly motivated and detail-oriented individual to join our team as a full-time Senior Accountant for supporting the corporate accounting and financial reporting & control functions. The successful applicant will be a key member of the finance team and will work with leaders across all company departments.Why Locus?Change the future of medicine and address a serious and unmet patient need by developing a completely novel therapeutic modality using CRISPR/Cas technologyFasttrack your career by tackling large & meaningful projectsWork with a team of exceptionally talented and hardworking individuals while striving to achieve a common missionPartner with the most highly respected pharmaceutical companies in the worldStock options & bonus pool eligibilityHealth, dental, vision, life insurance, 401(k), and PTOFree access to fitness center and classesResponsibilities will include:AccountingPerform and manage routine finance operations such as preparing purchase orders, invoice processing, bill payment, accounts payable, and accounts receivable.Maintaining and reconciling balance sheet and general ledger accounts.Maintain the general ledger.Enter transactions into NetSuite ERP systems such as invoices, purchase orders, vendor bills and making journal entries and reconciliations for period close.Perform routine maintenance and diagnostics on NetSuite ERP system and update system records, policies, workflows, etc. as needed.Assist with creating, implementing, and managing appropriate financial controls such as company financial policies.Create and maintain process documentation.Help research newly issued accounting standards as they are applicable to Locus and follow instruction from Chief Financial Officer on implementation procedures.Support month-end, quarter-end, and year-end close processesPrepare financial statements that are accurate and clear.Support external auditors in conducting year-end financial audit.Support external tax consultants in preparing corporate tax returns.Other related responsibilities as assigned. Budgeting and ForecastingWork with individual departments and Finance team to help prepare budgets and consolidate them into overall corporate budget.Support monthly and quarterly updates to financial forecast.Government ContractsPrepare invoices for government contracts based on established Excel template.Maintain and report on performance vs. budget for government contracts.With support of external consultant, ensure regulatory compliance with reporting requirements for government contracts.REQUIREMENTSEducationBachelor’s Degree in accounting or finance required.CPA preferred but not required.Experience and Expertise3+ years of accounting experience.Solid working knowledge of GAAP required.Strong financial analysis skills preferred.Experience working with Financial and ERP systems required (preferably NetSuite).Strong experience with Microsoft Excel required.Experience with Microsoft PowerPoint preferred.Preferred qualifications:Capable of effectively communicating with company executives and providing sound business judgement and financial acumen.Strong computer, analytical, organizational, communications, and interpersonal skills, with the ability to work effectively with colleagues at all levels of the organization and across all functions.Able to work effectively in a fast-moving and sometimes chaotic environment.Able to flex work hours to meet challenging deadlines.Impeccable integrity.About Locus BiosciencesLocus Biosciences is a clinical-stage biotechnology company developing precision antibacterial products to address critical unmet medical needs in treating bacterial infections and microbiome indications. The Locus platform engineers bacterial viruses called bacteriophages to specifically kill target pathogens while leaving non-target bacteria (i.e., the rest of the patient’s microbiome) unharmed and to deliver biotherapeutic payloads to the body sites where they are needed. Locus’s lead program is an engineered bacteriophage product targeting Escherichia coli bacteria in the urinary tract, currently being tested in an active Phase 2/3 clinical trial.